How do I install the Enda Monitor Pregnant Pai Patients skill?

Run npx skillmds@latest add dromlakhani/enda-monitor-pregnant-pai-patients in your terminal (requires Node.js), paste this page's agent-chat prompt into Claude, Cursor, or any MCP-connected agent, or download the SKILL.md file and copy it into your agent's skills directory.

Is Enda Monitor Pregnant Pai Patients safe to use?

This skill has not completed SkillMD's automated safety review yet. Independent scanners report: SkillSpector: PASS, Skill Scanner: PASS. Capability flags: docs only. SkillMD never runs a skill's scripts for you; review the SKILL.md before installing.

Which AI agents work with Enda Monitor Pregnant Pai Patients?

This skill is tagged as working with Claude Code, Claude.ai, OpenAI Codex. SKILL.md is an open format, so most agents that read a skills directory can load it too.

Is Enda Monitor Pregnant Pai Patients free to use?

Yes. Installing skills from SkillMD is free, and the skill stays under its author's original license.

Who published Enda Monitor Pregnant Pai Patients?

dromlakhani (@dromlakhani) published this skill. Their other Agent Skills are listed on their SkillMD profile.

Enda Monitor Pregnant Pai Patients by dromlakhani

Name: Enda Monitor Pregnant Pai Patients
Rating: 4.666666666666667 (3 reviews)
Author: dromlakhani

Enda Monitor Pregnant Pai Patients

Suggests that pregnant patients with primary adrenal insufficiency be monitored for clinical signs of glucocorticoid over- or under-replacement such as normal weight or gain, fatigue, postural hypotension or hypertension, and hyperglycemia, with at least one review each trimester. Use when managing a pregnant patient with PAI to assess glucocorticoid dosing adequacy.

dromlakhani Updated Sep 8, 2026 10 repo stars

File contents

Monitor Pregnant PAI Patients for Glucocorticoid Over- and Under-Replacement

STEP 1 — Gather Information

Collect maternal weight trends, self-reported fatigue, orthostatic blood pressure measurements (sitting and standing), fasting or random glucose, and review of current glucocorticoid dose and regimen.
Compile the data to assess for signs of glucocorticoid over- or under-replacement.

STEP 2 — Rule In / Rule Out

Determine if any of the following are present: abnormal weight trend (excessive gain or loss), new/worsening fatigue, postural hypotension (SBP drop >20 mmHg) or hypertension (SBP >140 mmHg), hyperglycemia (random glucose >140 mg/dL).
If any sign is present → proceed to Step 3; if none are present → continue routine prenatal care and reassess at the next trimester visit.

STEP 3 — Classify or Stratify

Classify the pattern: glucocorticoid over‑replacement suggested by weight gain, insomnia, peripheral edema, or hyperglycemia; glucocorticoid under‑replacement suggested by fatigue, weight loss, postural hypotension, hyperpigmentation, or nausea/vomiting.
Assign to over‑replacement, under‑replacement, or indeterminate category.

STEP 4 — Decide

If over‑replacement is suspected, consider reducing the glucocorticoid dose by 10‑20 %; if under‑replacement is suspected, consider increasing the dose by 10‑20 %; if indeterminate, maintain the current dose and schedule close clinical review in 2‑4 weeks.
Document the dose adjustment plan and arrange follow‑up assessment.

Clinical Guardrails / Mimics / Pitfalls

Symptoms such as fatigue, edema, and hyperglycemia can occur in normal pregnancy; avoid attributing all changes to glucocorticoid dosing without evaluating obstetric causes. Do not rely solely on serum cortisol or ACTH levels due to pregnancy‑induced increases in cortisol‑binding globulin. Ensure hyperglycemia is evaluated for gestational diabetes per standard prenatal care. Avoid abrupt dose changes; titrate gradually and monitor for adrenal crisis or Cushingoid signs.

Concrete Clinical Example

A 32‑year‑old woman with known PAI at 20 weeks gestation reports increased fatigue and occasional dizziness on standing; weight is stable; random glucose is 92 mg/dL. Orthostatic BP shows a systolic drop of 25 mmHg without edema. Clinical suspicion of glucocorticoid under‑replacement leads to an increase in hydrocortisone from 20 mg to 25 mg daily in divided doses, with reassessment in 2 weeks.

Source: Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2015-1710

---name: enda-monitor-pregnant-pai-patientsdescription: Suggests that pregnant patients with primary adrenal insufficiency be monitored for clinical signs of glucocorticoid over- or under-replacement such as normal weight or gain, fatigue, postural hypotension or hypertension, and hyperglycemia, with at least one review each trimester. Use when managing a pregnant patient with PAI to assess glucocorticoid dosing adequacy.---# Monitor Pregnant PAI Patients for Glucocorticoid Over- and Under-Replacement## STEP 1 — Gather InformationCollect maternal weight trends, self-reported fatigue, orthostatic blood pressure measurements (sitting and standing), fasting or random glucose, and review of current glucocorticoid dose and regimen. Compile the data to assess for signs of glucocorticoid over- or under-replacement.## STEP 2 — Rule In / Rule OutDetermine if any of the following are present: abnormal weight trend (excessive gain or loss), new/worsening fatigue, postural hypotension (SBP drop >20 mmHg) or hypertension (SBP >140 mmHg), hyperglycemia (random glucose >140 mg/dL). If any sign is present → proceed to Step 3; if none are present → continue routine prenatal care and reassess at the next trimester visit.## STEP 3 — Classify or StratifyClassify the pattern: glucocorticoid over‑replacement suggested by weight gain, insomnia, peripheral edema, or hyperglycemia; glucocorticoid under‑replacement suggested by fatigue, weight loss, postural hypotension, hyperpigmentation, or nausea/vomiting. Assign to over‑replacement, under‑replacement, or indeterminate category.## STEP 4 — DecideIf over‑replacement is suspected, consider reducing the glucocorticoid dose by 10‑20 %; if under‑replacement is suspected, consider increasing the dose by 10‑20 %; if indeterminate, maintain the current dose and schedule close clinical review in 2‑4 weeks. Document the dose adjustment plan and arrange follow‑up assessment.## Clinical Guardrails / Mimics / PitfallsSymptoms such as fatigue, edema, and hyperglycemia can occur in normal pregnancy; avoid attributing all changes to glucocorticoid dosing without evaluating obstetric causes. Do not rely solely on serum cortisol or ACTH levels due to pregnancy‑induced increases in cortisol‑binding globulin. Ensure hyperglycemia is evaluated for gestational diabetes per standard prenatal care. Avoid abrupt dose changes; titrate gradually and monitor for adrenal crisis or Cushingoid signs.## Concrete Clinical ExampleA 32‑year‑old woman with known PAI at 20 weeks gestation reports increased fatigue and occasional dizziness on standing; weight is stable; random glucose is 92 mg/dL. Orthostatic BP shows a systolic drop of 25 mmHg without edema. Clinical suspicion of glucocorticoid under‑replacement leads to an increase in hydrocortisone from 20 mg to 25 mg daily in divided doses, with reassessment in 2 weeks.**Source:** Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2015-1710

Frequently asked questions